154 related articles for article (PubMed ID: 9036738)
1. [Oncogenes and oncosuppressor role in head and neck carcinomas].
Pastore A; Pelucchi S; Mastrandrea M
Acta Otorhinolaryngol Ital; 1996 Jun; 16(3 Suppl 54):31-8. PubMed ID: 9036738
[No Abstract] [Full Text] [Related]
2. [Oncogenes and tumor suppressor genes in head and neck squamous cell carcinomas].
Maestro R; Dolcetti R
Acta Otorhinolaryngol Ital; 1996 Jun; 16(3 Suppl 54):21-6. PubMed ID: 9036736
[No Abstract] [Full Text] [Related]
3. Hereditary and environmental risk factors; clinical and laboratory risk matters for head and neck, especially oral, cancer and precancer.
Johnson NW; Warnakulasuriy S; Tavassoli M
Eur J Cancer Prev; 1996 Feb; 5(1):5-17. PubMed ID: 8664810
[TBL] [Abstract][Full Text] [Related]
4. TP53 and head and neck neoplasms.
Blons H; Laurent-Puig P
Hum Mutat; 2003 Mar; 21(3):252-7. PubMed ID: 12619110
[TBL] [Abstract][Full Text] [Related]
5. P53 codon 72 polymorphism in squamous cell carcinoma of the head and neck region.
Brant O; Hoffmann M; Kanappilly A; Görögh T; Gottschlich S
Anticancer Res; 2007; 27(5A):3301-5. PubMed ID: 17970074
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck.
Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M
Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018
[TBL] [Abstract][Full Text] [Related]
7. Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer.
Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S104-12. PubMed ID: 9071074
[TBL] [Abstract][Full Text] [Related]
8. Variability of genetic alterations in different sites of head and neck cancer.
Rodrigo JP; Suárez C; González MV; Lazo PS; Ramos S; Coto E; Alvarez I; García LA; Martínez JA
Laryngoscope; 2001 Jul; 111(7):1297-301. PubMed ID: 11568558
[TBL] [Abstract][Full Text] [Related]
9. Variation of p53 mutational spectra between carcinoma of the upper and lower respiratory tract.
Law JC; Whiteside TL; Gollin SM; Weissfeld J; El-Ashmawy L; Srivastava S; Landreneau RJ; Johnson JT; Ferrell RE
Clin Cancer Res; 1995 Jul; 1(7):763-8. PubMed ID: 9816043
[TBL] [Abstract][Full Text] [Related]
10. p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability.
Liloglou T; Scholes AG; Spandidos DA; Vaughan ED; Jones AS; Field JK
Cancer Res; 1997 Sep; 57(18):4070-4. PubMed ID: 9307295
[TBL] [Abstract][Full Text] [Related]
11. Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma.
Chang HW; Ling GS; Wei WI; Yuen AP
Cancer; 2004 Jul; 101(1):125-32. PubMed ID: 15221997
[TBL] [Abstract][Full Text] [Related]
12. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
[TBL] [Abstract][Full Text] [Related]
14. Rare loss-of-function mutation of a death receptor gene in head and neck cancer.
Pai SI; Wu GS; Ozören N; Wu L; Jen J; Sidransky D; El-Deiry WS
Cancer Res; 1998 Aug; 58(16):3513-8. PubMed ID: 9721851
[TBL] [Abstract][Full Text] [Related]
15. Molecular introduction to head and neck cancer (HNSCC) carcinogenesis.
Chin D; Boyle GM; Theile DR; Parsons PG; Coman WB
Br J Plast Surg; 2004 Oct; 57(7):595-602. PubMed ID: 15380692
[TBL] [Abstract][Full Text] [Related]
16. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck.
Field JK
Eur J Cancer B Oral Oncol; 1992 Jul; 28B(1):67-76. PubMed ID: 1330149
[TBL] [Abstract][Full Text] [Related]
17. Analysis of tumor suppressor p53 status in head and neck squamous cell carcinoma.
Smardova J; Ksicova K; Binkova H; Krpensky A; Pavlova S; Rottenberg J; Koukalova H
Oncol Rep; 2004 Apr; 11(4):923-9. PubMed ID: 15010896
[TBL] [Abstract][Full Text] [Related]
18. The interaction of oncogene and tumour suppressor gene defects with cytotoxic drugs: its role in the improvement of selective toxicity and the development of new drugs in clinical oncology.
Petty RD
Clin Oncol (R Coll Radiol); 1996; 8(3):186-9. PubMed ID: 8814375
[No Abstract] [Full Text] [Related]
19. [Analysis of oncogenes and tumor suppressor genes].
Sekiya T
Tanpakushitsu Kakusan Koso; 1993 Feb; 38(3):314-20. PubMed ID: 8488265
[No Abstract] [Full Text] [Related]
20. Transfer of chromosome 18 into human head and neck squamous carcinoma cells: evidence for tumor suppression by Smad4/DPC4.
Reiss M; Santoro V; de Jonge RR; Vellucci VF
Cell Growth Differ; 1997 Apr; 8(4):407-15. PubMed ID: 9101086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
